LIQUIDIA CORPORATION Basic Shares Outstanding (Weighted Average)
LIQUIDIA CORPORATION (LQDA) reported Basic Shares Outstanding (Weighted Average) of 88.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 88.89M shares, a 3.86% increase year-over-year.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 88.01M shares, a 3.33% increase year-over-year.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 87.13M shares, a 2.91% increase year-over-year.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 86.33M shares, a 10.24% increase year-over-year.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for fiscal 2025 was 86.06M shares, a 9.34% increase from fiscal 2024.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for fiscal 2024 was 78.71M shares, a 21.10% increase from fiscal 2023.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for fiscal 2023 was 64.99M shares, a 6.62% increase from fiscal 2022.
- LIQUIDIA CORPORATION weighted average number of shares outstanding, basic for fiscal 2022 was 60.96M shares, a 22.71% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 88.89M shares 10-Q · filed 2026-08-12 | 88.45M shares 10-Q · filed 2026-08-12 | 88.01M shares derived: average of 3 quarters · filed 2026-08-12 | 87.59M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 88.01M shares 10-Q · filed 2026-05-11 | 87.57M shares derived: average of 2 quarters · filed 2026-05-11 | 87.16M shares derived: average of 3 quarters · filed 2026-05-11 | 86.77M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 87.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 86.73M shares derived: average of 2 quarters · filed 2026-03-05 | 86.35M shares derived: average of 3 quarters · filed 2026-08-12 | 86.06M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 86.33M shares 10-Q · filed 2025-11-03 | 85.96M shares derived: average of 2 quarters · filed 2026-08-12 | 85.70M shares 10-Q · filed 2025-11-03 | 85.44M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 85.59M shares 10-Q · filed 2026-08-12 | 85.38M shares 10-Q · filed 2026-08-12 | 85.14M shares derived: average of 3 quarters · filed 2026-08-12 | 83.44M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 85.17M shares 10-Q · filed 2026-05-11 | 84.92M shares derived: average of 2 quarters · filed 2026-05-11 | 82.72M shares derived: average of 3 quarters · filed 2026-05-11 | 81.15M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 84.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 81.49M shares derived: average of 2 quarters · filed 2026-03-05 | 79.81M shares derived: average of 3 quarters · filed 2026-03-05 | 78.71M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 78.32M shares 10-Q · filed 2025-11-03 | 77.38M shares derived: average of 2 quarters · filed 2025-11-03 | 76.72M shares 10-Q · filed 2025-11-03 | 73.95M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | 76.44M shares 10-Q · filed 2025-08-12 | 75.91M shares 10-Q · filed 2025-08-12 | 72.50M shares derived: average of 3 quarters · filed 2026-03-05 | 70.59M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | 75.39M shares 10-Q · filed 2025-05-08 | 70.53M shares derived: average of 2 quarters · filed 2026-03-05 | 68.64M shares derived: average of 3 quarters · filed 2026-03-05 | 67.68M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | 65.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 65.26M shares derived: average of 2 quarters · filed 2026-03-05 | 65.11M shares derived: average of 3 quarters · filed 2026-03-05 | 64.99M shares 10-K · filed 2026-03-05 |
| 2023-09-30 | 64.86M shares 10-Q · filed 2024-11-13 | 64.82M shares derived: average of 2 quarters · filed 2024-11-13 | 64.77M shares 10-Q · filed 2024-11-13 | 64.73M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 64.79M shares 10-Q · filed 2024-08-07 | 64.72M shares 10-Q · filed 2024-08-07 | 64.68M shares derived: average of 3 quarters · filed 2024-08-07 | 64.63M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 64.66M shares 10-Q · filed 2024-05-13 | 64.63M shares derived: average of 2 quarters · filed 2024-05-13 | 64.57M shares derived: average of 3 quarters · filed 2024-05-13 | 63.97M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 64.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 64.53M shares derived: average of 2 quarters · filed 2024-03-13 | 63.75M shares derived: average of 3 quarters · filed 2024-03-13 | 60.96M shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 64.46M shares 10-Q · filed 2023-11-07 | 63.32M shares derived: average of 2 quarters · filed 2023-11-07 | 59.75M shares 10-Q · filed 2023-11-07 | 57.84M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 62.18M shares 10-Q · filed 2023-08-10 | 57.35M shares 10-Q · filed 2023-08-10 | 55.63M shares derived: average of 3 quarters · filed 2023-08-10 | 54.74M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 52.47M shares 10-Q · filed 2023-05-08 | 52.35M shares derived: average of 2 quarters · filed 2023-05-08 | 52.26M shares derived: average of 3 quarters · filed 2023-05-08 | 51.91M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 52.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 52.16M shares derived: average of 2 quarters · filed 2023-03-20 | 51.72M shares derived: average of 3 quarters · filed 2023-03-20 | 49.68M shares 10-K · filed 2023-03-20 |
| 2021-09-30 | 52.08M shares 10-Q · filed 2022-11-08 | 51.46M shares derived: average of 2 quarters · filed 2022-11-08 | 48.82M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 50.85M shares 10-Q · filed 2022-08-11 | 47.17M shares 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | 43.44M shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 33.89M shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |